GlobalData on MSN
Medtronic raises FY26 outlook amid cardiac ablation surge
Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.
The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
MedPage Today on MSN
Metformin Reduced Recurrent Atrial Arrhythmia After Afib Ablation
Over the 3 to 12 months following catheter ablation, patients who received metformin had greater freedom from recurrent ...
A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...
Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...
The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.
An open-label study shows that patients who took metformin after catheter ablation for atrial fibrillation have significantly ...
Medpage Today on MSN
Major Trial Sours on Blanket DOAC Therapy After Successful Afib Ablation
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...
Dr. Mark Shen performed the surgery using a new system called “Affera Mapping and Ablation” to treat atrial fibrillation.
Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
News-Medical.Net on MSN
Anticoagulants increase bleeding post-ablation with no added stroke benefit
A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results